Latest from NOVAiCOS
Newspaper articles, press releases, events and corporate updates to stay informed about our progress.
Oncology patent recognized in the United States
We are excited to announce that last week NOVAiCOS ImmunoTherapeutics received…
Read on LinkedIn-
Mar 2025NOVAiCOS obtained from the European Patent Office the notification of acceptance of the corresponding European Patent as well
Read more -
Mar 2025Brand new, completely revisited NOVAiCOS ImmunoTherapeutics website!
Read more -
Dec 2024UPO – University of Eastern Piedmont
NOVAiCOS: a step forward in Immune Therapy for Cancer!
Read more -
Dec 2024NOVAiCOS ImmunoTherapeutics gets full IP ownership
NOVAiCOS ImmunoTherapeutics (NIT) is thrilled to announce that it has recently acquired…
Read more -
Dec 2024Landing Page & Brand-new Logo
Today our new landing page is on-line, with the brand-new logo testifying…
Read more -
Nov 2024Investment round – reserved to Family & Friends of the current NOVAiCOS
We are thrilled to announce that the investment round…
Read more -
Sep 2024NOVAiCOS ImmunoTherapeutics Small Medium Enterprise
Today it’s just 3 months that NOVAiCOS has obtained the status of Innovative SME…
Read more -
Jul 2024The new venue of NOVAiCOS ImmunoTherapeutics
Thank you to all stakeholders, colleagues & friends who joined us yesterday to…
Read more -
Jul 2024Let’s celebrate the new headquarters together!
Here is the entrance of BioIndustry Park, with the…
Read more -
Jul 2024Let’s celebrate the new headquarters together!
Join us on Jul 16, h. 16:00 – 18:00 CEST, BioIndustry Park, near Ivrea…
Read more